CONCEPT: A 1-Year Comparison Of A Stable Dose Of SERETIDE® Inhaler With An Adjustable Maintenance Dose Of SYMBICORT® Inhaler. SERETIDE® Inhaler is a Trademark of GSK Group of Companies. SYMBICORT® Inhaler is a Trademark of Astra Zeneca.

NCT00479739 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

700

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Salmeterol/fluticasone propionate or formoterol/budesonide

Sponsor

GlaxoSmithKline